ATC code L01
Abemaciclib
Acalabrutinib
Aclarubicin
Afatinib
Aflibercept
Alectinib
Alemtuzumab
Alkylating antineoplastic agent
Alpelisib
American Society of Health-System Pharmacists
Amivantamab
Anaplastic lymphoma kinase
Anatomical Therapeutic Chemical Classification System
Anthracycline
Antifolate
Antimetabolite
Antineoplastic
Asciminib
Atezolizumab
Aumolertinib
Avapritinib
Avelumab
Axatilimab
Axitinib
Azacitidine
BRAF (gene)
Baricitinib
Belantamab mafodotin
Bermekimab
Bevacizumab
Binimetinib
Bleomycin
Blinatumomab
Bortezomib
Bosutinib
Brentuximab vedotin
Brigatinib
Bruton's tyrosine kinase
Busulfan
CAS Registry Number
CD135
CD20
CD30
CD33
CD3 (immunology)
CD52
CDK inhibitor
Cabozantinib
Camptothecin
Cancer immunotherapy
Capecitabine
Capmatinib
Carboplatin
Carmustine
Catumaxomab
Cediranib
Cemiplimab
Ceritinib
Cetuximab
Chemical formula
Chemotherapy
Chlorambucil
Chlormethine
Cisplatin
Cladribine
Clofarabine
Cobimetinib
Colorectal cancer
CompTox Chemicals Dashboard
Copanlisib
Cosibelimab
Crizotinib
Cyclin-dependent kinase
Cyclophosphamide
Cytarabine
DNA replication
Dabrafenib
Dacarbazine
Dacomitinib
DailyMed
Dalpiciclib
Daratumumab
Dasatinib
Daunorubicin
Decitabine
Denileukin diftitox
Docetaxel
Dostarlimab
Doxorubicin
Durvalumab
Duvelisib
EML4
Edrecolomab
Elotuzumab
Elranatamab
Encorafenib
Enfortumab vedotin
Entrectinib
Epcoritamab
Epidermal growth factor receptor
Epirubicin
Epothilone
ErbB
Erdafitinib
Erlotinib
Etoposide
Everolimus
Exotoxin
Fedratinib
Fibroblast growth factor receptor
Filgotinib
Fludarabine
Fluorouracil
Food and Drug Administration
Fotemustine
Fruquintinib
Fusion protein
Futibatinib
Gefitinib
Gemcitabine
Gemtuzumab ozogamicin
Gilteritinib
Glasdegib
Glofitamab
Hedgehog signaling pathway
Ibritumomab tiuxetan
Ibrutinib
Icotinib
Idarubicin
Idelalisib
Ifosfamide
Imatinib
Inavolisib
Infigratinib
Inotuzumab ozogamicin
Interleukin 2
Ipilimumab
Irinotecan
Isatuximab
Janus kinase
KRAS
Lapatinib
Lung cancer
Molar mass
Public domain